Abiomed, Inc.ABMDNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank10
5Y CAGR-35.4%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-35.4%/yr
Long-term compound
Percentile
P10
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2022 | 0.68% |
| Q2 2022 | 2.07% |
| Q1 2022 | 4.88% |
| Q4 2021 | 3.33% |
| Q3 2021 | 5.60% |
| Q2 2021 | -1.81% |
| Q1 2021 | 5.30% |
| Q4 2020 | 6.46% |
| Q3 2020 | 7.09% |
| Q2 2020 | 3.48% |
| Q1 2020 | 2.00% |
| Q4 2019 | 6.01% |
| Q3 2019 | -1.34% |
| Q2 2019 | 6.72% |
| Q1 2019 | 9.91% |
| Q4 2018 | 7.18% |
| Q3 2018 | 8.61% |
| Q2 2018 | 4.37% |
| Q1 2018 | 8.84% |
| Q4 2017 | 4.31% |
| Q3 2017 | 6.08% |
| Q2 2017 | 24.53% |
| Q1 2017 | 7.94% |
| Q4 2016 | 4.02% |
| Q3 2016 | 4.82% |
| Q2 2016 | 1.49% |
| Q1 2016 | 6.64% |
| Q4 2015 | 3.87% |
| Q3 2015 | 6.13% |
| Q2 2015 | 4.32% |
| Q1 2015 | 47.84% |
| Q4 2014 | 10.38% |
| Q3 2014 | 2.06% |
| Q2 2014 | 0.55% |
| Q1 2014 | 4.35% |
| Q4 2013 | 5.58% |
| Q3 2013 | 5.07% |
| Q2 2013 | 2.46% |
| Q1 2013 | 3.31% |
| Q4 2012 | -3.25% |